A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.
Rajiv AgarwalBertram PittBiff F PalmerCsaba Pal KovesdyEllen BurgessGerasimos FilippatosJolanta MałyszkoLuis M RuilopePatrick RossignolEllen BurgessRoberto Pecoits-FilhoStefan D AnkerAmer JosephRobert LawatscheckDaniel WilsonMartin GebelGeorge L BakrisPublished in: Clinical kidney journal (2022)
AMBER (NCT03071263), FIDELIO-DKD (NCT02540993), FIGARO-DKD (NCT02545049).